Literature DB >> 15892931

Circadian phase shifting, alerting, and antidepressant effects of bright light treatment.

Teodor T Postolache1, Dan A Oren.   

Abstract

Bright light treatment is the most potent melatonin suppressor and circadian phase shifter and is a safe nonpharmacologic antidepressant for seasonal depression. In addition, bright light treatment may restore performance in conditions of sleep debt and misalignment between peak performance and the athletic event. This article discusses the therapeutic use of bright light treatment, its side effects, and mechanisms of action.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15892931     DOI： 10.1016/j.csm.2004.12.005

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN： 0278-5919            Impact factor:   2.182


  11 in total

Review 1.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

2.  Mood-worsening with high-pollen-counts and seasonality: a preliminary report.

Authors:  Alvaro Guzman; Leonardo H Tonelli; Darryl Roberts; John W Stiller; Michael A Jackson; Joseph J Soriano; Samina Yousufi; Kelly J Rohan; Hirsh Komarow; Teodor T Postolache
Journal:  J Affect Disord       Date:  2007-01-12       Impact factor: 4.839

Review 3.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

4.  Corticotropin-releasing factor critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol.

Authors:  Mahendra Wagle; Priya Mathur; Su Guo
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

5.  Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.

Authors:  Jared W Young; Zackary A Cope; Benedetto Romoli; Esther Schrurs; Jordy van Enkhuizen; Richard F Sharp; Davide Dulcis
Journal:  Neuropsychopharmacology       Date:  2018-02-27       Impact factor: 7.853

Review 6.  Environmental Design for End-of-Life Care: An Integrative Review on Improving the Quality of Life and Managing Symptoms for Patients in Institutional Settings.

Authors:  Rana Sagha Zadeh; Paul Eshelman; Judith Setla; Laura Kennedy; Emily Hon; Aleksa Basara
Journal:  J Pain Symptom Manage       Date:  2017-09-19       Impact factor: 3.612

7.  Does activity matter: an exploratory study among mothers with preterm infants?

Authors:  Shih-Yu Lee; Carol H Grantham; Susan Shelton; Dana Meaney-Delman
Journal:  Arch Womens Ment Health       Date:  2012-04-18       Impact factor: 3.633

8.  Converging evidence that short-active photoperiod increases acetylcholine signaling in the hippocampus.

Authors:  Zackary A Cope; Maria L Lavadia; Aniek J M Joosen; Chuck J A van de Cappelle; Joseph C Lara; Alexandra Huval; Molly K Kwiatkowski; Marina R Picciotto; Yann S Mineur; Davide Dulcis; Jared W Young
Journal:  Cogn Affect Behav Neurosci       Date:  2020-12       Impact factor: 3.282

9.  Reading increases ocular illuminance during light treatment.

Authors:  Aamar Sleemi; Mary A Johnson; Kelly J Rohan; Olaoluwa Okusaga; Timileyin Adediran; Hyacinth Uzoma; Chantelle Walsh; Gloria Reeves; Teodor T Postolache
Journal:  Int J Adolesc Med Health       Date:  2012

Review 10.  Sleep in elite athletes and nutritional interventions to enhance sleep.

Authors:  Shona L Halson
Journal:  Sports Med       Date:  2014-05       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.